---
granola_id: d8576918-d6c6-4e0a-9afc-733410d16195
title: "Virtue / Autonomy"
type: note
created: 2025-11-14T19:35:51.966Z
updated: 2025-11-14T20:02:38.911Z
attendees:
  - natalie@autonomyhealth.io
  - rooshil@autonomyhealth.io
  - sd@virtuevc.com
---
### MSO Contract Opportunities

- Texas practice full MSO contract with infusions secured
	- Migration and billing capability confirmed
	- $500k - $1.5m net revenue potential from infusions
	- 40% margin initially, scaling to 60% with volume discounts
	- Structure and revenue split still TBD due to existing contract complications
	- Ideal customer proving the thesis with strong drug rates in Texas BCBS
- North Carolina practice offer extended
	- AllScripts contract ends 2026, interested in switching
	- $4-5M collections, already has in-house infusions
	- 12% take rate proposed, reducing costs from $700k to $500k
	- 30% margin scaling to 50% (lower than Texas due to rates)
	- Timing intentionally delayed to avoid dual launches
	- Potential imaging addition under discussion

### Pharma and Revenue Model Clarifications

- Revenue structure operates on net collections model
	- $500k to Autonomy generates 40% margin ($200k cash)
	- No contract ownership, unlike mental health MSOs
	- Infusion risk-sharing: 80% risk for 80% margin potential
- Pharma purchasing and rebate structure needs legal review
	- OIC and AIC lawyers meeting scheduled next week
	- Challenge: purchasing drugs without NPI/DEA numbers
	- Rebate negotiation directly with pharma if Autonomy purchases
- Conference connections with Genentech and Revamps
	- Interest in authorization data and financial assistance integration
	- Genentech reevaluating Salmicare relationship for Ocrevus
	- February follow-up meetings scheduled
- GPO and specialty pharmacy expansion potential
	- Neural Net exploring specialty GPO contracts
	- Integrated dispensing model opportunity emerging
	- Partnership approach preferred over direct pharmacy operations

### Hiring and Development Challenges

- Harry declined offer citing work-life balance concerns
	- Positive: clarity before onboarding vs. discovering later
	- Candidate quality improving but closing remains difficult
- Contractor setbacks with existing team
	- James and Will performing excellently
	- Two new contractors fell through same week (university admission, W2 offer)
	- Monday interview scheduled for additional contractor
- Development timeline impact
	- Texas practice supportive of delays with transparent communication
	- 3 weeks behind ideal schedule but migration timeline provides buffer
	- Balancing short-term execution needs with long-term talent quality
- Pending introductions requested
	- Single Sprout contact for development talent
	- Alloyd introduction for additional hiring support

Chat with meeting transcript: https://notes.granola.ai/d/d8576918-d6c6-4e0a-9afc-733410d16195
